Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • cement_head
    Senior Member
    • Mar 2012
    • 265

    #1

    Is the HiSeq2500 DOA?

    Is the HiSeq2500 being phased out? In other words, has it reached EOL and/or is Illumina ceasing to provide supply reagents?

    Thanks,
    Andor
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Not in immediate future AFAIK. Reagents should be available into early 2020's. Someone may have saved that letter from Illumina and will provide specifics.

    Comment

    • cement_head
      Senior Member
      • Mar 2012
      • 265

      #3
      Okay, I guess it's just that the "cost per base" is significantly higher than the 3000/4000 series; that's why we're seeing a reduction in availability. It's too bad because they don't suffer from the INDEX hopping issue.

      Comment

      • gringer
        David Eccles (gringer)
        • May 2011
        • 845

        #4
        I'd expect that they do suffer from index hopping, because there's a chemistry component to that as well as a machine component.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
          by SEQadmin2




          NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
          Today, 06:46 AM
        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-28-2026, 09:57 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-28-2026, 09:51 AM
        0 responses
        15 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        68 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        48 views
        0 reactions
        Last Post SEQadmin2  
        Working...